<DOC>
	<DOCNO>NCT00911300</DOCNO>
	<brief_summary>The purpose study test whether Fondaparinux effective safe prevent thromboembolic event ( like example stroke ) bleed event patient undergo normalisation heart rhythm disturbance . Fondaparinux compare Heparin tablet contain Vitamin-K-Antagonists ( Phenprocoumon , Fluindione , Warfarin ) .</brief_summary>
	<brief_title>Evaluation Fondaparinux Patients With Heart Rhythm Disturbance Who Undergo Restoration Normal Heart Rhythm</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Male female patient age least 18 year atrial fibrillation ( AF ) meeting least one follow criterion ( , b , c ) : . Acute clinical symptom ( like palpitation , chest pain , dyspnea , fatigue , lightheadedness , syncope ) least 48 hour AF baseline ECG b . Newly discover AF persist &gt; =7 day c. Recurrent AF persist &gt; =7 day No document sinus rhythm ECG 1 year Acute neurological deficit ( TIA , stroke , intracranial bleeding ) , know disease may cause neurological deficit ( e.g. , multiple sclerosis , seizure disorder ) Treatment antithrombotic agent , include lowdose anticoagulation , 48 hour prior randomisation Treatment oral NSAIDs ASA dose great 325 mg per day 72 hour prior randomisation Anticoagulant therapy require likely required study period Treatment ASA dose great 325 mg per day oral NSAIDs ( dose ) require likely require study period Treatment two antiplatelet agent ( e.g . clopidogrel ASA ) dose time ( i.e. , within 24 hour ) Known hypersensitivity UFH , VKA , Fondaparinux one drug ' excipients Active , clinically significant bleed clinically significant bleeding within past month Major surgery within previous three month Uncontrolled arterial hypertension ( persistent systolic blood pressure 180 mm Hg diastolic blood pressure 110 mm Hg ) Bacterial endocarditis Calculated creatinine clearance &lt; 30 mL/min Body weight &lt; 50 kg Planned surgery intervention within next 65 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cardioversion , Electric</keyword>
	<keyword>Pathological Conditions , Sings Symptoms</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Arrhythmias , Cardiac</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Anticoagulants</keyword>
</DOC>